Ovary removal in BRCA1 carriers cuts breast cancer risk
This article was originally published in Clinica
Women who carry the BRCA1 breast cancer gene mutation could reduce their risk of developing the disease by 70% if they have both their ovaries removed, according to a US study.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.